Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 350706, 9 pages
http://dx.doi.org/10.1155/2010/350706
Review Article

Cardiac Troponin Mutations and Restrictive Cardiomyopathy

Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Room 6085A, RMSB, 1600 NW 10th Avenue, Miami, FL 33136, USA

Received 13 November 2009; Accepted 22 February 2010

Academic Editor: Aikaterini Kontrogianni-Konstantopoulos

Copyright © 2010 Michelle S. Parvatiyar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Gordon, E. Homsher, and M. Regnier, “Regulation of contraction in striated muscle,” Physiological Reviews, vol. 80, no. 2, pp. 853–924, 2000. View at Google Scholar · View at Scopus
  2. A. M. Gordon, M. Regnier, and E. Homsher, “Skeletal and cardiac muscle contractile activation: tropomyosin “rocks and rolls”,” News in Physiological Sciences, vol. 16, no. 2, pp. 49–55, 2001. View at Google Scholar · View at Scopus
  3. B. C. Knollmann, P. Kirchhof, S. G. Sirenko et al., “Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling,” Circulation Research, vol. 92, no. 4, pp. 428–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. X. Li, L. Spyracopoulos, and B. D. Sykes, “Binding of cardiac troponin-I 147-163 induces a structural opening in human cardiac troponin-C,” Biochemistry, vol. 38, no. 26, pp. 8289–8298, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Takeda, A. Yamashita, K. Maeda, and Y. Maéda, “Structure of the core domain of human cardiac troponin in the Ca2+-saturated form,” Nature, vol. 424, no. 6944, pp. 35–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. S. Farah, C. A. Miyamoto, C. H. I. Ramos et al., “Structural and regulatory functions of the NH2- and COOH-terminal regions of skeletal muscle troponin I,” Journal of Biological Chemistry, vol. 269, no. 7, pp. 5230–5240, 1994. View at Google Scholar · View at Scopus
  7. K. Murakami, F. Yumoto, S.-Y. Ohki, T. Yasunaga, M. Tanokura, and T. Wakabayashi, “Structural basis for Ca2+-regulated muscle relaxation at interaction sites of troponin with actin and tropomyosin,” Journal of Molecular Biology, vol. 352, no. 1, pp. 178–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Morris, L. S. Tobacman, and E. Homsher, “Modulation of contractile activation in skeletal muscle by a calcium-insensitive troponin C mutant,” Journal of Biological Chemistry, vol. 276, no. 23, pp. 20245–20251, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. D. F. A. McKillop and M. A. Geeves, “Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament,” Biophysical Journal, vol. 65, no. 2, pp. 693–701, 1993. View at Google Scholar · View at Scopus
  10. A. J. G. Moir, R. J. Solaro, and S. V. Perry, “The site of phosphorylation of troponin I in the perfused rabbit heart. The effect of adrenaline,” Biochemical Journal, vol. 185, no. 2, pp. 505–513, 1980. View at Google Scholar · View at Scopus
  11. T. A. Noland Jr., X. Guo, R. L. Raynor et al., “Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca2+-stimulated MgATPase of reconstituted actomyosin S-1,” Journal of Biological Chemistry, vol. 270, no. 43, pp. 25445–25454, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Kentish, D. T. McCloskey, J. Layland et al., “Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle,” Circulation Research, vol. 88, no. 10, pp. 1059–1065, 2001. View at Google Scholar · View at Scopus
  13. K. P. Ray and P. J. England, “Phosphorylation of the inhibitory subunit of troponin and its effects on the calcium dependence of cardiac myofibril adenosine triphosphatase,” FEBS Letters, vol. 70, no. 1, pp. 11–16, 1976. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Solaro, A. J. G. Moir, and S. V. Perry, “Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart,” Nature, vol. 262, no. 5569, pp. 615–617, 1976. View at Google Scholar · View at Scopus
  15. R. Zhang, J. Zhao, A. Mandveno, and J. D. Potter, “Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation,” Circulation Research, vol. 76, no. 6, pp. 1028–1035, 1995. View at Google Scholar · View at Scopus
  16. D. E. Michele, M. L. Szatkowski, F. P. Albayya, and J. M. Metzger, “Parvalbumin gene delivery improves diastolic function in the aged myocardium in vivo,” Molecular Therapy, vol. 10, no. 2, pp. 399–403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Zhang, J. Zhao, and J. D. Potter, “Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C,” Journal of Biological Chemistry, vol. 270, no. 51, pp. 30773–30780, 1995. View at Google Scholar · View at Scopus
  18. B. Malnic, C. S. Farah, and F. C. Reinach, “Regulatory properties of the NH2- and COOH-terminal domains of troponin T: ATPase activation and binding to troponin I and troponin C,” Journal of Biological Chemistry, vol. 273, no. 17, pp. 10594–10601, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Pearlstone and L. B. Smillie, “Effects of troponin-I plus-C on the binding of troponin-T and its fragments to α-tropomyosin. Ca2+ sensitivity and cooperativity,” Journal of Biological Chemistry, vol. 258, no. 4, pp. 2534–2542, 1983. View at Google Scholar · View at Scopus
  20. S. P. White, C. Cohen, and G. N. Phillips Jr., “Structure of co-crystals of tropomyosin and troponin,” Nature, vol. 325, no. 6107, pp. 826–828, 1987. View at Google Scholar · View at Scopus
  21. A. S. Zot and J. D. Potter, “Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction,” Annual Review of Biophysics and Biophysical Chemistry, vol. 16, pp. 535–559, 1987. View at Google Scholar · View at Scopus
  22. R. Maytum, M. A. Geeves, and S. S. Lehrer, “A modulatory role for the troponin T tail domain in thin filament regulation,” Journal of Biological Chemistry, vol. 277, no. 33, pp. 29774–29780, 2002. View at Google Scholar · View at Scopus
  23. L. S. Tobacman, “Structure-function studies of the amino-terminal region of bovine cardiac troponin T,” Journal of Biological Chemistry, vol. 263, no. 6, pp. 2668–2672, 1988. View at Google Scholar · View at Scopus
  24. A. Hinkle, A. Goranson, C. A. Butters, and L. S. Tobacman, “Roles for the troponin tail domain in thin filament assembly and regulation: a deletional study of cardiac troponin T,” Journal of Biological Chemistry, vol. 274, no. 11, pp. 7157–7164, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. L. S. Tobacman, M. Nihli, C. Butters et al., “The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity,” Journal of Biological Chemistry, vol. 277, no. 31, pp. 27636–27642, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. X.-P. Huang and J.-F. Du, “Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy,” Acta Pharmacologica Sinica, vol. 25, no. 12, pp. 1569–1575, 2004. View at Google Scholar · View at Scopus
  27. S. E. Hughes and W. J. McKenna, “New insights into the pathology of inherited cardiomyopathy,” Heart, vol. 91, no. 2, pp. 257–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Angelini, V. Calzolari, G. Thiene et al., “Morphologic spectrum of primary restrictive cardiomyopathy,” American Journal of Cardiology, vol. 80, no. 8, pp. 1046–1050, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. S. S. Kushwaha, J. T. Fallon, and V. Fuster, “Restrictive cardiomyopathy,” The New England Journal of Medicine, vol. 336, no. 4, pp. 267–276, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Rivenes, D. L. Kearney, E. O. Smith, J. A. Towbin, and S. W. Denfield, “Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy,” Circulation, vol. 102, no. 8, pp. 876–882, 2000. View at Google Scholar · View at Scopus
  31. S.-C. Chen, I. C. Balfour, and S. Jureidini, “Clinical spectrum of restrictive cardiomyopathy in children,” Journal of Heart and Lung Transplantation, vol. 20, no. 1, pp. 90–92, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. T. Kimberling, D. T. Balzer, R. Hirsch, E. Mendeloff, C. B. Huddleston, and C. E. Canter, “Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome,” Journal of Heart and Lung Transplantation, vol. 21, no. 4, pp. 455–459, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. S. B. Peddy, L. A. Vricella, J. E. Crosson et al., “Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene,” Pediatrics, vol. 117, no. 5, pp. 1830–1833, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Feld and A. Caspi, “Familial cardiomyopathy with variable hypertrophic and restrictive features and common HLA haplotype,” Israel Journal of Medical Sciences, vol. 28, no. 5, pp. 277–280, 1992. View at Google Scholar · View at Scopus
  35. J. Mogensen, T. Kubo, M. Duque et al., “Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 209–216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Kostareva, A. Gudkova, G. Sjoberg et al., “Deletion in TNNI3 gene is associated with restrictive cardiomyopathy,” International Journal of Cardiology, vol. 131, no. 3, pp. 410–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. P. Kaski, P. Syrris, M. Burch et al., “Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes,” Heart, vol. 94, no. 11, pp. 1478–1484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. J. R. Pinto, M. S. Parvatiyar, M. A. Jones, J. Liang, and J. D. Potter, “A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin,” Journal of Biological Chemistry, vol. 283, no. 4, pp. 2156–2166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Kubo, J. R. Gimeno, A. Bahl et al., “Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype,” Journal of the American College of Cardiology, vol. 49, no. 25, pp. 2419–2426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Yumoto, Q.-W. Lu, S. Morimoto et al., “Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy,” Biochemical and Biophysical Research Communications, vol. 338, no. 3, pp. 1519–1526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. V. Gomes, J. Liang, and J. D. Potter, “Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development,” Journal of Biological Chemistry, vol. 280, no. 35, pp. 30909–30915, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Davis, H. Wen, T. Edwards, and J. M. Metzger, “Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 5, pp. 891–904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Wen, Y. Xu, Y. Wang, J. R. Pinto, J. D. Potter, and W. G. L. Kerrick, “Functional effects of a restrictive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice,” Journal of Molecular Biology, vol. 392, no. 5, pp. 1158–1167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Kobayashi and R. J. Solaro, “Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I,” Journal of Biological Chemistry, vol. 281, no. 19, pp. 13471–13477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. T. S. Rai, S. Ahmad, T. S. Ahluwalia et al., “Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy,” Molecular and Cellular Biochemistry, vol. 331, no. 1-2, pp. 187–192, 2009. View at Google Scholar · View at Scopus
  46. J. Davis, H. Wen, T. Edwards, and J. M. Metzger, “Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling,” Circulation Research, vol. 100, no. 10, pp. 1494–1502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. F. I. Gambarin, M. Tagliani, and E. Arbustini, “Pure restrictive cardiomyopathy associated with cardiac troponin I gene mutation: mismatch between the lack of hypertrophy and the presence of disarray,” Heart, vol. 94, no. 10, p. 1257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-F. Forissier, P. Richard, S. Briault et al., “First description of germline mosaicism in familial hypertrophic cardiomyopathy,” Journal of Medical Genetics, vol. 37, no. 2, pp. 132–134, 2000. View at Google Scholar · View at Scopus
  49. H. Watkins, L. Thierfelder, D.-S. Hwang, W. McKenna, J. G. Seidman, and C. E. Seidman, “Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations,” Journal of Clinical Investigation, vol. 90, no. 5, pp. 1666–1671, 1992. View at Google Scholar · View at Scopus
  50. S. Karam, M.-J. Raboisson, C. Ducreux et al., “A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy,” Congenital Heart Disease, vol. 3, no. 2, pp. 138–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. S. C. Menon, V. V. Michels, P. A. Pellikka et al., “Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology,” Clinical Genetics, vol. 74, no. 5, pp. 445–454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Watkins, W. J. McKenna, L. Thierfelder et al., “Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy,” The New England Journal of Medicine, vol. 332, no. 16, pp. 1058–1064, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. Varnava, P. M. Elliott, C. Baboonian, F. Davison, M. J. Davies, and W. J. McKenna, “Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease,” Circulation, vol. 104, no. 12, pp. 1380–1384, 2001. View at Google Scholar · View at Scopus
  54. E. M. Rust, F. P. Albayya, and J. M. Metzger, “Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins,” Journal of Clinical Investigation, vol. 103, no. 10, pp. 1459–1467, 1999. View at Google Scholar · View at Scopus
  55. T. Miller, D. Szczesna, P. R. Housmans et al., “Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation,” Journal of Biological Chemistry, vol. 276, no. 6, pp. 3743–3755, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Westermann, B. C. Knollmann, P. Steendijk et al., “Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy,” European Journal of Heart Failure, vol. 8, no. 2, pp. 115–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Wen, J. R. Pinto, A. V. Gomes et al., “Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice,” Journal of Biological Chemistry, vol. 283, no. 29, pp. 20484–20494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. D. S. Wood, M. M. Sorenson, A. B. Eastwood, W. E. Charash, and J. P. Reuben, “Duchenne dystrophy: abnormal generation of tension and Ca++ regulation in single skinned fibers,” Neurology, vol. 28, no. 5, pp. 447–457, 1978. View at Google Scholar · View at Scopus
  59. D. S. Wood, J. Zollman, J. P. Reuben, and P. W. Brandt, “Human skeletal muscle: properties of the ‘chemically skinned’ fiber,” Science, vol. 187, no. 4181, pp. 1075–1076, 1975. View at Google Scholar · View at Scopus
  60. J. Mogensen and E. Arbustini, “Restrictive cardiomyopathy,” Current Opinion in Cardiology, vol. 24, no. 3, pp. 214–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. N. M. Ammash, J. B. Seward, K. R. Bailey, W. D. Edwards, and A. J. Tajik, “Clinical profile and outcome of idiopathic restrictive cardiomyopathy,” Circulation, vol. 101, no. 21, pp. 2490–2496, 2000. View at Google Scholar · View at Scopus
  62. J. Du, C. Zhang, J. Liu, C. Sidky, and X. P. Huang, “A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice,” Archives of Biochemistry and Biophysics, vol. 456, no. 2, pp. 143–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Du, J. Liu, H.-Z. Feng et al., “Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI,” American Journal of Physiology, vol. 294, no. 6, pp. H2604–H2613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. A. M. Murphy, L. Jones II, H. F. Sims, and A. W. Strauss, “Molecular cloning of rat cardiac troponin I and analysis of troponin I isoform expression in developing rat heart,” Biochemistry, vol. 30, no. 3, pp. 707–712, 1997. View at Google Scholar · View at Scopus
  65. J. M. Metzger, D. E. Michele, E. M. Rust, A. R. Borton, and M. V. Westfall, “Sarcomere thin filament regulatory isoforms: evidence of a dominant effect of slow skeletal troponin I on cardiac contraction,” Journal of Biological Chemistry, vol. 278, no. 15, pp. 13118–13123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. S. V. Perry, “Troponin T: genetics, properties and function,” Journal of Muscle Research and Cell Motility, vol. 19, no. 6, pp. 575–602, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. L. S. Tobacman and R. Lee, “Isolation and functional comparison of bovine cardiac troponin T isoforms,” Journal of Biological Chemistry, vol. 262, no. 9, pp. 4059–4064, 1987. View at Google Scholar · View at Scopus
  68. A. V. Gomes, G. Guzman, J. Zhao, and J. D. Potter, “Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development: insights into the role of troponin T isoforms in the heart,” Journal of Biological Chemistry, vol. 277, no. 38, pp. 35341–35349, 2002. View at Publisher · View at Google Scholar · View at Scopus